SCHEMBL8304869

SCHEMBL8304869

C/C(=N/OCCO)c1ccc(-c2ccc(C(F)(F)F)cc2)cc1

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PPARG P37231 3/20 0.52
PPARA Q07869 3/20 0.52
S1PR1 P21453 4/20 0.51
LMNA P02545 4/20 0.44
SMN1; SMN2 Q16637 3/20 0.44
PTBP1 P26599 1/20 0.44
CYP1A2 P05177 2/20 0.42
CYP3A4 P08684 2/20 0.42
CYP2D6 P10635 2/20 0.42
CYP2C9 P11712 2/20 0.42
CYP2C19 P33261 2/20 0.42
HIF1A Q16665 2/20 0.42
MEN1 O00255 2/20 0.42
KMT2A Q03164 2/20 0.42
NFKB1 P19838 1/20 0.42
SLC6A2 P23975 1/20 0.42
SLC6A4 P31645 1/20 0.42
ADRA1A P35348 1/20 0.42
OPRK1 P41145 1/20 0.42
SLC6A3 Q01959 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8304871 1.00 PPARG (0.52) PPARGPPARAS1PR1LMNASMN1; SMN2
SCHEMBL8304589 0.95 PPARA (0.55) PPARGPPARAS1PR1LMNASMN1; SMN2
SCHEMBL5609899 0.83 LMNA (0.65) PPARGPPARAS1PR1LMNASMN1; SMN2
SCHEMBL5609892 0.83 LMNA (0.65) PPARGPPARAS1PR1LMNASMN1; SMN2
SCHEMBL8443076 0.82 LMNA (0.42) PPARGPPARAS1PR1LMNASMN1; SMN2
SCHEMBL14418609 0.82 SLC6A4 (0.60) PPARGPPARAS1PR1LMNASMN1; SMN2
SCHEMBL5610797 0.81 LMNA (0.56) PPARGPPARAS1PR1LMNASMN1; SMN2
SCHEMBL8309933 0.81 PPARA (0.48) PPARGPPARAS1PR1LMNASMN1; SMN2
SCHEMBL8309932 0.81 PPARA (0.48) PPARGPPARAS1PR1LMNASMN1; SMN2
SCHEMBL5610798 0.81 LMNA (0.56) PPARGPPARAS1PR1LMNASMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5972959-A Oxime derivatives, their preparation and their therapeutic use SANKYO COMPANY, LIMITED (JP) 1999-10-26 US disclosed
EP-0708098-B1 Oxime derivatives, their preparation and their therapeutic use SANKYO CO (JP) 1999-03-03 EP disclosed
EP-0708098-A1 Oxime derivatives, their preparation and their therapeutic use SANKYO COMPANY LIMITED (JP) 1996-04-24 EP disclosed